Apimeds Pharmaceuticals Us Inc (APUS) Stock Price, Quote, News & History

APUSAMEX
$1.28
0.032.40%
At close: Jun 12, 5:00 PM EST
Loading...

Key Statistics

Open
$1.55
Close
$1.28
Volume / Avg.
24.76K / 190.30K
Day Range
$1.21 - $1.55
52 Wk Range
1.10 - 40.31
Market Cap
$19.47M
P/E Ratio
-
Dividend Yield
-
Exchange
AMEX
RSI
31
Short Interest
2.07%
Days to Cover
5.08

Recent Apimeds Pharmaceuticals US Inc News

No news found

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-10.97M
Investing Cash Flow (TTM)
-9.57M
Financing Cash Flow (TTM)
21.27M
Free Cash Flow (TTM)
-11.04M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
729.19K

Valuation Metrics

Enterprise Value
$26.45M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
0.15
Earnings Yield % (TTM)
-222.02%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$8.38

Company Debt

Total Debt
$9.36M
LT Debt
-
LT Debt Issuance (TTM)
$11.00M
LT Debt Repayment (TTM)
-
Total Cash
$979.53K
Debt to Equity
0.08
Issuance of Debt (TTM)
$11.00M
Repayment of Debt (TTM)
-

Key Statistics

Open
$1.55
Close
$1.28
Volume / Avg.
24.76K / 190.30K
Day Range
$1.21 - $1.55
52 Wk Range
1.10 - 40.31
Market Cap
$19.47M
P/E Ratio
-
Dividend Yield
-
Exchange
AMEX
RSI
31
Short Interest
2.07%
Days to Cover
5.08

About

Sector
Health Care
Industry
Biotechnology
Apimeds Pharmaceuticals Us Inc is a development-stage biopharmaceutical company. The Company operates its biopharmaceutical business. Its primary focus is the clinical development of Apitox, a purified honeybee venom-based drug candidate being evalua...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Apimeds Pharmaceuticals (APUS) stock?

A

You can purchase shares of Apimeds Pharmaceuticals (AMEX:APUS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Apimeds Pharmaceuticals (APUS) competitors?

A

There are no as such competitors for Apimeds Pharmaceuticals.

Q

What is the forecast, or price target, for Apimeds Pharmaceuticals (APUS) stock?

A

There is no analysis for Apimeds Pharmaceuticals to provide a consensus price target.

Q

What is the current price for Apimeds Pharmaceuticals (APUS)?

A

The stock price for Apimeds Pharmaceuticals (AMEX: APUS) is $1.29 last updated June 12, 2026 at 3:49 PM EDT.

Q

Does Apimeds Pharmaceuticals (APUS) pay a dividend?

A

There are no upcoming dividends for Apimeds Pharmaceuticals.

Q

When is Apimeds Pharmaceuticals (AMEX:APUS) reporting earnings?

A

Apimeds Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Apimeds Pharmaceuticals (APUS) going to split?

A

There is no upcoming split for Apimeds Pharmaceuticals.

Q

What sector and industry does Apimeds Pharmaceuticals (APUS) operate in?

A

Apimeds Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.